Twist Bioscience (TWST) Free Cash Flow (2017 - 2026)

Twist Bioscience (TWST) has reported Free Cash Flow for 10 consecutive years, with -$8.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Free Cash Flow rose 18.14% year-over-year to -$8.6 million in Q2 2026; TTM through Jun 2026 was -$93.1 million, a 35.52% decrease from a year earlier, with the FY2025 full-year figure at -$75.6 million, down 9.34% from the prior year.
• Free Cash Flow was -$8.6 million for Q2 2026 at Twist Bioscience, up from -$25.4 million in the prior quarter.
• Over five years, Free Cash Flow peaked at -$7.3 million in Q2 2024 and troughed at -$74.8 million in Q2 2022.
• A 5-year average of -$30.6 million and a median of -$24.0 million in 2024 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow sank 125.52% in 2022 and surged 73.7% in 2024, its largest moves.
• Over 5 years, Free Cash Flow stood at -$65.9 million in 2022, then soared by 62.85% to -$24.5 million in 2023, then increased by 3.2% to -$23.7 million in 2024, then plunged by 46.81% to -$34.8 million in 2025, then soared by 75.14% to -$8.6 million in 2026.
• The last three Free Cash Flow figures came in at -$8.6 million (Q2 2026), -$25.4 million (Q1 2026), and -$34.8 million (Q4 2025), per Business Quant data.